日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Repurposing the anthelmintic drug mebendazole in combination with radiation therapy in an isocitrate dehydrogenase mutant glioma model

在异柠檬酸脱氢酶突变型胶质瘤模型中,将驱虫药甲苯咪唑与放射疗法联合应用

Yamashita, Alex Shimura; da Costa Rosa, Marina; Riggins, Gregory J

Phase 1 study of mebendazole therapy for refractory/progressive or recurrent pediatric brain tumors

甲苯咪唑治疗难治性/进展性或复发性儿童脑肿瘤的I期研究

Phan, Paul; Stapleton, Stacie L; Riggins, Gregory J; Koldobskiy, Michael A; Raabe, Eric; Cohen, Kenneth J

TERT and BRAF V600E mutations in thyroid cancer of World Trade Center Responders

世界贸易中心救援人员甲状腺癌中的TERT和BRAF V600E突变

van Gerwen, Maaike; Cerutti, Janete Maria; Mendes, Thais Biude; Brody, Rachel; Genden, Eric; Riggins, Gregory J; Taioli, Emanuela

Author Correction: Atrx inactivation drives disease-defining phenotypes in glioma cells of origin through global epigenomic remodeling

作者更正:Atrx 失活通过全局表观基因组重塑驱动神经胶质瘤起源细胞的疾病定义表型

Danussi, Carla; Bose, Promita; Parthasarathy, Prasanna T; Silberman, Pedro C; Van Arnam, John S; Vitucci, Mark; Tang, Oliver Y; Heguy, Adriana; Wang, Yuxiang; Chan, Timothy A; Riggins, Gregory J; Sulman, Erik P; Lang, Frederick F; Creighton, Chad J; Deneen, Benjamin; Miller, C Ryan; Picketts, David J; Kannan, Kasthuri; Huse, Jason T

Evaluation of a DNA demethylating agent in combination with all-trans retinoic acid for IDH1-mutant gliomas

评估DNA去甲基化剂联合全反式维甲酸治疗IDH1突变型胶质瘤的疗效

da Costa Rosa, Marina; Yamashita, Alex Shimura; Riggins, Gregory J

Impact of international research fellows in neurosurgery: results from a single academic center

国际研究员对神经外科的影响:来自单一学术中心的研究结果

Yang, Wuyang; Rincon-Torroella, Jordina; Feghali, James; Khalafallah, Adham M; Ishida, Wataru; Perdomo-Pantoja, Alexander; Quiñones-Hinojosa, Alfredo; Lim, Michael; Gallia, Gary L; Riggins, Gregory J; Anderson, William S; Lo, Sheng-Fu Larry; Rigamonti, Daniele; Tamargo, Rafael J; Witham, Timothy F; Bydon, Ali; Cohen, Alan R; Jallo, George I; Latremoliere, Alban; Luciano, Mark G; Mukherjee, Debraj; Olivi, Alessandro; Qu, Lintao; Gokaslan, Ziya L; Sciubba, Daniel M; Tyler, Betty; Brem, Henry; Huang, Judy

Evaluation of a procaspase-3 activator with hydroxyurea or temozolomide against high-grade meningioma in cell culture and canine cancer patients

在细胞培养和犬类癌症患者中评估procaspase-3激活剂联合羟基脲或替莫唑胺对高级别脑膜瘤的疗效

Tonogai, Emily J; Huang, Shan; Botham, Rachel C; Berry, Matthew R; Joslyn, Stephen K; Daniel, Gregory B; Chen, Zixin; Rao, Jianghong; Zhang, Xiang; Basuli, Falguni; Rossmeisl, John H; Riggins, Gregory J; LeBlanc, Amy K; Fan, Timothy M; Hergenrother, Paul J

The glutamine antagonist prodrug JHU-083 slows malignant glioma growth and disrupts mTOR signaling

谷氨酰胺拮抗剂前药JHU-083可减缓恶性胶质瘤的生长并干扰mTOR信号通路。

Yamashita, Alex Shimura; da Costa Rosa, Marina; Stumpo, Vittorio; Rais, Rana; Slusher, Barbara S; Riggins, Gregory J

Mebendazole disrupts stromal desmoplasia and tumorigenesis in two models of pancreatic cancer

甲苯咪唑可干扰两种胰腺癌模型中的基质增生和肿瘤发生

Williamson, Tara; de Abreu, Michelle Carvalho; Trembath, Dimitri G; Brayton, Cory; Kang, Byunghak; Mendes, Thais Biude; de Assumpção, Paulo Pimentel; Cerutti, Janete M; Riggins, Gregory J

Tunable Stability of Imidazotetrazines Leads to a Potent Compound for Glioblastoma

咪唑并四嗪类化合物的可调稳定性使其成为治疗胶质母细胞瘤的有效化合物

Svec, Riley L; Furiassi, Lucia; Skibinski, Christine G; Fan, Timothy M; Riggins, Gregory J; Hergenrother, Paul J